title: High initial multidrug-resistant tuberculosis rate in Buenaventura, Colombia: a public-private initiative.
authors.forename: Sonia L
authors.initials: SL
authors.lastname: Villegas
authors.forename: Beatriz E
authors.initials: BE
authors.lastname: Ferro
authors.forename: Carlos M
authors.initials: CM
authors.lastname: Perez-Velez
authors.forename: Cesar A
authors.initials: CA
authors.lastname: Moreira
authors.forename: Liliana
authors.initials: L
authors.lastname: Forero
authors.forename: Ernesto
authors.initials: E
authors.lastname: Martínez
authors.forename: Nalin
authors.initials: N
authors.lastname: Rastogi
authors.forename: Jose Antonio
authors.initials: JA
authors.lastname: Caminero
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000995:Antitubercular Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003105:Colombia; D003140:Communicable Disease Control / Q000379:methods; D005260:Female; D006801:Humans; D055552:Infectious Disease Medicine / Q000379:methods; D007538:Isoniazid / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000378:metabolism; D017149:Private Sector; D011634:Public Health; D017150:Public Sector; D012293:Rifampin / Q000494:pharmacology; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy*
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin